‌

US Patent 8987272 Compounds and method for treatment of HIV

Patent 8987272 was granted and assigned to Critical Outcome Technologies, Inc. on March, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

‌

Critical Outcome Technologies, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

89872720

Patent Inventor Names

Wayne Danter0

Clinton Threlfall0

Julien Marin0

Sylvain Guizzetti0

Date of Patent

March 24, 2015

Patent Application Number

136385970

Date Filed

April 1, 2011

Patent Primary Examiner

‌

Paul V Ward

Patent abstract

The invention relates to a compound of Formulae I and/or II:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8987272 Compounds and method for treatment of HIV

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API